内皮祖细胞对药物洗脱支架置入术后再狭窄及再内皮化影响的研究进展(1)
[摘要] 经皮冠状动脉介入治疗是目前治疗冠心病的主要手段，但支架内再狭窄严重影响了其长期疗效。研究发现，支架内再狭窄的发生主要与内皮损伤、再内皮化延迟有关。快速完全的再内皮化是预防支架内再狭窄的重要方法。而内皮祖细胞在受损内皮再修复的过程中起重要作用，有研究发现通过促进内皮祖细胞动员、移植内皮祖细胞或者捕获循环中的内皮祖细胞等方式，促进其增殖、迁移、分化及归巢，可以加速受损血管的再内皮化，这为有效防止支架内再狭窄提供了一个很好的研究方向。
[关键词] 内皮祖细胞；支架内再狭窄；再内皮化
[中图分类号] R541.4 [文献标识码] A [文章编号] 1674-4721(2016)08(c)-0054-04
[Abstract] Percutaneous coronary intervention is the major means in the treatment of coronary heart disease， but in-stent restenosis seriously affect its long-term efficacy. Studies have found that the occurrence of in-stent restenosis is mainly associated with endothelial injury and the delay of re-endothelialization. Fast and complete re-endothelial is an important way to prevent stent re-stenosis. While ......
您现在查看是摘要页，全文长 4125 字符。
[关键词] 内皮祖细胞；支架内再狭窄；再内皮化
[中图分类号] R541.4 [文献标识码] A [文章编号] 1674-4721(2016)08(c)-0054-04
[Abstract] Percutaneous coronary intervention is the major means in the treatment of coronary heart disease， but in-stent restenosis seriously affect its long-term efficacy. Studies have found that the occurrence of in-stent restenosis is mainly associated with endothelial injury and the delay of re-endothelialization. Fast and complete re-endothelial is an important way to prevent stent re-stenosis. While ......
您现在查看是摘要页，全文长 4125 字符。